Abbott is committed to presenting information with accuracy and integrity. As part of our effort to provide the most reliable and safe medical products, notices will be posted here when there is important information to share. If you have any questions or concerns, please contact your Abbott representative or Abbott Customer Service at 1-866-240-6741.
In August 2024, Abbott provided a letter to patients and physicians regarding a system update available to correct the issue with the Liberta RC™ DBS System stimulation turning off at approximately 50-day intervals. This is a follow-up communication to the previous communication from May 2024. Please find the physician and patient communication documents below for further information.
Liberta RC™ DBS System Important Information for Patients - August 8, 2024
Liberta RC™ DBS System Important Information for Physicians - August 8, 2024
In June 2024, Abbott issued an Urgent Medical Device Correction regarding the implantable pulse generator (IPG) battery elective replacement indicator (ERI) for patients with non-rechargeable Proclaim™ SCS Family, Proclaim™ DRG Neurostimulation System and Infinity™ DBS System. The duration between the IPG reaching ERI threshold and end of service (EOS) may be shorter than indicated in the product labeling. Please find the below physician communication document for further information.
Infinity™ DBS System Important Information for Physicians - June 7, 2024
In May 2024, Abbott issued an Urgent Medical Device Recall regarding stimulation turning off at approximately 50-day intervals on the Liberta RC™ DBS System. Please find the below physician and patient communication document for further information.
Liberta RC™ DBS System Important Information for Patients - May 24, 2024
Liberta RC™ DBS System Important Information for Physicians - May 24, 2024
Abbott issued an Urgent Medical Device Correction communicating the risk of the inability to exit magnetic resonance imaging (MRI) mode if the Patient Controller has lost the ability to connect or communicate with the IPG while in MRI mode. This applies to the Proclaim™ XR SCS System, Proclaim™ Elite SCS System, Proclaim™ Plus SCS System, Proclaim™ DRG Neurostimulation System and Infinity™ DBS System.
In October 2023, Abbott issued letters to affected SCS and DRG patients and DBS healthcare providers (HCPs). These are subsequent letters to the original healthcare provider letter dated on July 2023.
Please find the communication documents below for further information.
Infinity™ DBS System - MRI Mode Important Information for HCPs - October 5, 2023
Infinity™ DBS System - MRI Mode Important Information for Patients - October 5, 2023
In July 2023, Abbott issued an Urgent Medical Device Correction notice to customers communicating the risk of the inability to exit magnetic resonance imaging (MRI) mode if the Patient Controller has lost the ability to connect or communicate with the IPG while in MRI mode. This applies to the Proclaim™ XR SCS System, Proclaim™ Elite SCS System, Proclaim™ Plus SCS System, Proclaim™ DRG Neurostimulation System and Infinity™ DBS System. Please find the communication document below for further information.
On November 11, 2019, Abbott provided an Urgent Medical Device Recall notice to customers communicating that a single lot of Classic Radiofrequency Cannula—Curved (Model C-1005-S) were manufactured with a 10-mm active tip length instead of the labeled 5-mm active tip length. Please find the communication document below for further information.
Classic Radiofrequency Cannula - Curved Important Information - November 11, 2019
On October 14, 2019, Abbott provided an Urgent Medical Device Recall notice to customers communicating that a select number of Radiofrequency Grounding Pads (Model RF-DGP-L) were manufactured with the protective release liner in an incorrect orientation. Please find the communication document below for further information.
Radiofrequency Grounding Pad Important Information – October 14, 2019
On October 29, 2018, Abbott provided an Urgent Medical Device Recall notice to customers communicating that a select number of 8-Channel Leads for the St. Jude Medical Infinity™ DBS System may contain an electrode that was not manufactured to our material specification which causes it to appear lighter under radiography. Please find the below physician communication document with patient management recommendations for further information.
On October 11, 2018, Abbott provided an Urgent Medical Device Recall notice to customers communicating that a select number of 8-Channel Leads for the St. Jude Medical Infinity™ DBS System may contain an electrode that was not manufactured to our material specification which causes it to appear lighter under radiography. Please find the below hospital communication documents for further information.
On March 14, 2018, Abbott provided an Important Medical Device Advisory to physicians regarding the Proclaim™ DRG Neurostimulation System implantable pulse generator (IPG) (model: 3664).
On September 12, 2017, Abbott provided an Important Medical Device Advisory to physicians regarding the Proclaim™ SCS IPG devices, Proclaim™ DRG IPG devices and Infinity™ Deep Brain Stimulation (DBS) IPG devices in which a software calculation error has caused the elective replacement indicator (ERI) in some devices has triggered earlier than intended.
Read the Important Medical Device Advisory documents and FAQ documents for details regarding risk and patient management recommendations.
PROCLAIM™ SCS FAMILY AND PROCLAIM™ DRG NEUROSTIMULATION SYSTEM DEVICES
INFINITY™ DBS IPG DEVICES
PDF Important Medical Device Advisory: Infinity™ DBS IPG devices – September 12, 2017
ADDITIONAL RESOURCES
On June 2, 2017, St. Jude Medical provided an Important Medical Device Advisory to physicians regarding the St. Jude Medical implantable pulse generator (IPG) devices implanted before June 2, 2017, for Proclaim™ Elite SCS IPG (models: 3660 and 3662) and Infinity™ DBS IPG (models: 6660, 6661, 6662, and 6663).
On July 21, 2014, St. Jude Medical provided an update letter to physicians regarding Eon™ implantable pulse generators. This is an update to the previous voluntary device correction letter, dated December 19, 2011. See both physician letters and a patient safety information letter below:
Important Medical Device Correction Update: Eon™ Charging System – July 2014
Important Medical Device Safety Information: Eon™ Charging System – July 2014
On July 26, 2012, St. Jude Medical provided an update letter to physicians regarding the Eon Mini™ implantable pulse generator. This is an update to the previous voluntary recall notification letter, dated May 24, 2011. See both letters below:
Updated Medical Device Information: Eon Mini™ IPG – July 2012
Important Medical Device Information: Eon Mini™ IPG – May 2011
On July 21, 2012, St. Jude Medical provided an update letter to physicians regarding Eon™ and Eon Mini™ implantable pulse generators. This is an update to the previous voluntary device correction letter, dated December 19, 2011. See both physician letters and a patient safety information letter below:
Updated Medical Device Information: Eon™ and Eon Mini™ IPGs – July 2012
Important Medical Device Information: Eon™ and Eon Mini™ IPGs – December 2011
On December 19, 2011, St. Jude Medical provided a letter to physicians regarding the Eon Mini™ implantable pulse generator.
PDF Important Medical Device Information: Eon Mini™ IPG – December 2011
24-97357 MAT-1900937 v8.0 | Item approved for U.S. use only.
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
© 2024 Abbott. All Rights Reserved.
24-90211 2011056 v9.0 | Item approved for U.S. use only.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.
72188 MAT-2214515 v1.0 | Item approved for U.S. use only.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
72184 MAT-2214513 v1.0 | Item approved for U.S. use only.
Chronic Pain